As part of the Company''s strategic growth and expansion initiatives, it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its ....

27.07.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SYMBOL:- EPIGRAL Scrip Code: 543332 Dear Sirs, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) – Outcome of Board Meeting We are pleased to inform you that, as part of the Company's strategic growth and expansion initiatives, it proposes to establish a new manufacturing facility for Epoxy Resin & Formulations and Multi-Purpose Plant (MPP) at its existing facility at Dahej, Gujarat. The details of the abovementioned capital expenditure as required to be furnished pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 are provided in Annexure A. You are requested to take the same on your record. Thanking You, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. A22307 ANNEXURE - A Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January, 2026 Sr. No. Particulars Product 1. Name of the Product Epoxy Resin & Multi-Purpose Plant Formulations (MPP) 2. Existing Capacity N.A. N.A. 3. Proposed Capacity 1,25,000 TPA N.A. 4. Period within which the By H2 FY2028 By H2 FY2028 Proposed Capacity is to be added 5. Investment required Estimated Rs. 600 Cr. 6. Mode of Financing Mix of Debt and Internal Accruals 7. Rationale To expand the product portfolio and meet the growing demand